Breaking News
Sort by:
Top Post
Fujifilm Europe Launches New Hybrid C-arm and Portable X-ray Device
The FDR CROSS platform provides advanced fluoroscopic and radiographic imaging, powered by Fujifilm’s FDR D-EVO […]
Accelerate Diagnostics Announces Commercialization in Europe of Its Accelerate Arc™ System Having Completed IVDR Registration
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global […]
Smart CRP Test Gets Green Light for Professional Use as Swiss Medtech Company Expands Across Europe
Swiss medtech company Bloom Diagnostics has today announced the launch of the Bloom Inflammation Test, […]
Implanet Announces a Commercial, Technological and Financial Partnership With Sanyou Medical, a Chinese Manufacturer of Medical Devices for Spine Surgery
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company […]
H.E.L Group Releases iso-BTC+ Calorimeter for Isothermal Battery Performance Testing
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, […]
Bio-Rad Introduces CFX Opus Deepwell Real-Time PCR Detection System
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS
Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, […]
Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis
Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced […]
Carthera Receives FDA Breakthrough Device Designation for SonoCloud-9 System
Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to […]
BIOTEM Implements New Industrial Unit Dedicated to Development and Production of Immunoassays
BIOTEM, a hybrid Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) focusing on high […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more